SOLVENTUM CORP (SOLV) Stock News
NYSE:SOLV - New York Stock Exchange, Inc. - US83444M1018 - Common Stock - Currency: USD
SOLV Latest News, Press Relases and Analysis
What's going on in today's session: S&P500 movers
Uncover the latest developments among S&P500 stocks in today's session. Stay tuned to the S&P500 index's top gainers and losers on Wednesday.
Which S&P500 stocks are gapping on Wednesday?
Wondering which stocks are making significant price gaps? Explore the S&P500 index on Wednesday to find the gap up and gap down stocks in today's session.
Firing on All Cylinders: CONMED (NYSE:CNMD) Q1 Earnings Lead the Way
Looking back on surgical equipment & consumables - diversified stocks’ Q1 earnings, we examine this quarter’s best and worst performers, including CONMED (NYSE:CNMD) and its peers.
Mentions: CNMD
3 of Wall Street’s Favorite Stocks Walking a Fine Line
The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because analysts typically say nice things about companies so their firms can win business in other product lines like M&A advisory.
Solventum (SOLV) Just Overtook the 200-Day Moving Average
When a stock breaks out above the 200-day simple moving average, good things could be on the horizon. How should investors react?
Stay informed with the top movers within the S&P500 index on Friday.
Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Friday.
What's going on in today's session: S&P500 movers
Uncover the latest developments among S&P500 stocks in today's session. Stay tuned to the S&P500 index's top gainers and losers on Friday.
Solventum Stock Gains on Q1 Earnings & Revenue Beat, Margins Decline
SOLV's first-quarter earnings showcase strong segmental performance. However, declining margins raise concerns.
Solventum (SOLV) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
Although the revenue and EPS for Solventum (SOLV) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Solventum (SOLV) Tops Q1 Earnings and Revenue Estimates
Solventum (SOLV) delivered earnings and revenue surprises of 12.61% and 3.37%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Mentions: EMBC
Solventum to Participate in the 2025 BofA Securities Health Care Conference
/PRNewswire/ -- Solventum (NYSE: SOLV) announced today its executives will participate in a fireside chat at the 2025 BofA Securities Health Care Conference on...
Solventum Reports First Quarter 2025 Financial Results
/PRNewswire/ -- Solventum (NYSE: SOLV) today reported financial results for the first quarter ended March 31, 2025. First Quarter 2025 Highlights Sales...
Solventum Q1 Earnings Likely to Reflect Higher Costs & Expenses
SOLV's Q1 performance is likely to have been hurt by below-par revenue growth in several markets, coupled with currency headwinds. Improved pricing might have offset the sales decline.
SOLV vs. DOCS: Which Stock Is the Better Value Option?
SOLV vs. DOCS: Which Stock Is the Better Value Option?
Mentions: DOCS
Solventum Corporation (SOLV): Among the Best New Stocks to Buy According to Billionaires
We recently published a list of 10 Best New Stocks to Buy According to Billionaires. In this article, we are going to take a look at where Solventum Corporation (NYSE:SOLV) stands against other best new stocks to buy according to billionaires. Overview of Q1 2025 IPO Activity International IPO activity during the first quarter of […]
Solventum Corporation (SOLV): Among Billionaire Nelson Peltz’s Stock Picks with Highest Upside Potential
We recently published a list of Billionaire Nelson Peltz’s 8 Stock Picks with Highest Upside Potential. In this article, we are going to take a look at where Solventum Corporation (NYSE:SOLV) stands against other billionaire Nelson Peltz’s stock picks with highest upside potential. Nelson Peltz is one of the renowned figures in the financial world […]
Solventum to Report First Quarter Fiscal 2025 Earnings on May 8, 2025
/PRNewswire/ -- Solventum (NYSE: SOLV) will release its first quarter fiscal 2025 financial results on Thursday, May 8, 2025, after the U.S. financial markets...
Solventum Corporation (NYSE:SOLV): Is the Spin-Off a Blessing in Disguise?
We came across a bullish thesis on Solventum Corporation (NYSE:SOLV) on ValueInvestorsClub by GCA. In this article, we will summarize the bulls’ thesis on SOLV. The company’s shares were trading at $74.24 when this thesis was published, vs. the closing price of $66.19 on Apr 11. SOLV is a healthcare company that develops, manufactures, and […]
Solventum Partners With SprintRay for Same-Day Dental Restorations
SOLV partners with SprintRay to introduce an innovative solution for same-day dental restorations, enhancing efficiency, precision and patient care in digital dentistry.
Solventum partners with SprintRay to disrupt the digital dentistry market with high-quality, permanent same-day restorations
/PRNewswire/ -- Solventum (NYSE: SOLV), the leader in dental composites and restorative dentistry, today announced a strategic partnership with SprintRay, a...